Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up

Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up

Background: Steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS) significantly affect children’s quality of life. There are frequent relapses in SSNS and progression in SRNS. IPNA guidelines suggest that monoclonal antibodies like rituximab (RTX) are promising...

Full description

Saved in:
Bibliographic Details
Main Authors: Dmytro Ivanov, Lutz T. Weber, Elena Levtchenko, Liudmyla Vakulenko, Mariia Ivanova, Iryna Zavalna, Yelizaveta Lagodych, Ninel Boiko
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Biomedicines
Subjects:
SRNS
SSNS
rituximab
pediatric nephrotic syndrome
B-cell depletion therapy
Online Access:https://www.mdpi.com/2227-9059/12/11/2600
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items